Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
出版年份 2022 全文链接
标题
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
作者
关键词
SARS-CoV-2, COVID-19 testing, COVID-19, Serological Testing, Immunoassay, Spike, Nucleocapsid, IgG
出版物
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Volume -, Issue -, Pages 115659
出版商
Elsevier BV
发表日期
2022-02-12
DOI
10.1016/j.diagmicrobio.2022.115659
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
- (2021) Vincent Legros et al. Cellular & Molecular Immunology
- The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers
- (2021) Sheila F Lumley et al. CLINICAL INFECTIOUS DISEASES
- Antibody persistence in the first six months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
- (2021) Arnaud G. L’Huillier et al. CLINICAL MICROBIOLOGY AND INFECTION
- SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline
- (2021) Shelly Bolotin et al. JOURNAL OF INFECTIOUS DISEASES
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Neutralizing antibody titres in SARS-CoV-2 infections
- (2021) Eric H. Y. Lau et al. Nature Communications
- Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers
- (2021) Jan Van Elslande et al. CLINICAL INFECTIOUS DISEASES
- SARS‐CoV‐2 re‐infection risk in Austria
- (2021) Stefan Pilz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
- (2021) Jan Van Elslande et al. JOURNAL OF CLINICAL VIROLOGY
- Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for up to 10 Months after Infection
- (2021) Julien Favresse et al. Microorganisms
- SARS-CoV-2 Antibody Kinetics Eight Months from COVID-19 Οnset: Persistence of Spike Antibodies but Loss of Neutralizing Antibodies in 24% of Convalescent Plasma Donors
- (2021) Evangelos Terpos et al. European Journal of Internal Medicine
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
- (2021) Christian Holm Hansen et al. LANCET
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
- (2021) Carlota Dobaño et al. BMC Medicine
- Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
- (2021) Javier Perez-Saez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study
- (2021) Mar Masiá et al. JOURNAL OF AUTOIMMUNITY
- The fall in antibody response to SARS-CoV-2: a longitudinal study of asymptomatic to critically ill patients up to 10 months after recovery
- (2021) Maddalena Peghin et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study
- (2021) Sabrina Kral et al. JOURNAL OF INFECTION
- Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection
- (2021) Pyoeng Gyun Choe et al. JOURNAL OF INFECTIOUS DISEASES
- Over 1‐year duration and age difference of SARS‐CoV‐2 antibodies in convalescent COVID‐19 patients
- (2021) Fanfan Zeng et al. JOURNAL OF MEDICAL VIROLOGY
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS‐CoV ‐2 antibody persistence in COVID ‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance
- (2021) Clara Di Germanio et al. TRANSFUSION
- Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
- (2021) Floriane Gallais et al. EBioMedicine
- Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
- (2021) Charles F. Schuler et al. Microbiology Spectrum
- Impact of Age and Sex on Antibody Response Following the Second Dose of COVID-19 BNT162b2 mRNA Vaccine in Greek Healthcare Workers
- (2021) Niki Vassilaki et al. Microorganisms
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
- (2021) Laith J. Abu-Raddad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Protective immunity after recovery from SARS-CoV-2 infection
- (2021) Noah Kojima et al. LANCET INFECTIOUS DISEASES
- Waning Immunity after the BNT162b2 Vaccine in Israel
- (2021) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
- (2021) Barak Mizrahi et al. Nature Communications
- Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
- (2021) Margherita Rosati et al. Frontiers in Immunology
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Jiuxin Qu et al. CLINICAL INFECTIOUS DISEASES
- Diagnostic performance of 7 rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
- (2020) Jan Van Elslande et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs
- (2020) Jan Van Elslande et al. CLINICAL MICROBIOLOGY AND INFECTION
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- (2020) AJ Jääskeläinen et al. JOURNAL OF CLINICAL VIROLOGY
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
- (2020) Amin Addetia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now